VASCULAR ANOMALY
Clinical trials for VASCULAR ANOMALY explained in plain language.
Never miss a new study
Get alerted when new VASCULAR ANOMALY trials appear
Sign up with your email to follow new studies for VASCULAR ANOMALY, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Cancer drug shows promise for rare vascular conditions in kids and young adults
Disease control OngoingThis study tests the drug alpelisib, already approved for some breast cancers, in people aged 2 months to 30 years with rare blood vessel growth disorders caused by specific gene changes. Participants take the drug for 2-3 years and attend up to 16 clinic visits to check if the t…
Matched conditions: VASCULAR ANOMALY
Phase: PHASE2 • Sponsor: Children's Hospital of Philadelphia • Aim: Disease control
Last updated May 17, 2026 07:39 UTC
-
Cancer drug shows promise for rare blood vessel disorders in kids
Disease control OngoingThis study tests the drug trametinib, already approved for melanoma, in people aged 2 months to 30 years with rare blood vessel growth problems caused by a specific gene pathway. The goal is to see if the drug can shrink abnormal vessels and improve quality of life. Participants …
Matched conditions: VASCULAR ANOMALY
Phase: PHASE2 • Sponsor: Children's Hospital of Philadelphia • Aim: Disease control
Last updated May 11, 2026 20:39 UTC
-
New imaging technique sheds light on lymphatic disorders
Diagnosis ENROLLING_BY_INVITATIONThis study uses a safe, near-infrared dye and a special camera to take pictures of the lymphatic system. Researchers want to see how lymph fluid moves in healthy people and in those with conditions like lymphedema, lipedema, or vascular malformations. The goal is to better unders…
Matched conditions: VASCULAR ANOMALY
Sponsor: The University of Texas Health Science Center, Houston • Aim: Diagnosis
Last updated May 17, 2026 07:51 UTC